TECH Estadísticas clave
Alto
72.12
Abrir
71.60
Volumen
3.07M
Bajo
71.50
Cierre anterior
71.77
Valor negociado
221.03M
Máx. 52 sem.
72.16
Volumen rel.
0.367
Amplitud (%)
0.86%
Mín. 52 sem.
43.20
Tasa de rotación
1.96%
Cap. de Mercado
11.18B
PER (TTM)
103.59
PER (Anual)
153.447
P/B
5.39
P/S
9.28
Beneficio por acción (BPA)
0.696
Dividendo (TTM)
0.317
Rentabilidad por dividendo
0.45%
Acciones en circulación
156.56M
Moneda
USD
TECH Rendimiento del Precio
7 día
30 día
90 día
180 día
En lo que va del año
1 Año
TECH Distribución del flujo de dinero
TECH Volumen diario de ventas en corto
TECH Historial de short interest
Resumen de la acción TECH
As of 2026-07-18, the Bio-Techne Corp (TECH) stock price today is 72.12. Based on this price, the company has a market capitalization of $11.18B, with a P/E ratio of 103.59.
On 2026-07-18, TECH traded between 71.50 and 72.12. Today’s stock price is 0.87% above the daily low and 0.00% below the daily high, placing TECH de cerca del extremo superior de its most recent trading range.
Trading volume currently stands at 3.07M, compared with an average daily volume of 8.38M. This suggests that trading activity is significativamente por debajo de su nivel habitual than usual.
Over the past year, Bio-Techne Corp shares have traded between 43.20 and 72.16. At today’s price, TECH is 66.94% above its 52-week low and 0.06% below its 52-week high.
TECH Noticias relacionadas
Acerca de TECH
Nombre empresa
Bio-Techne Corp
Sector
Health Technology
Industria
Biotechnology
Intercambios
Nasdaq
Número de empleados
3,100
Tamaño del lote
100
Sitio oficial
Moneda
USD
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.
Related Stocks
© 2026 CoinGlass, all rights reserved
